Display Settings:

Format

Send to:

Choose Destination

    Neuropeptides. 1992 Feb;21(2):81-4.

    Gastrin releasing peptide (GRP) binding sites in human bronchi.

    Baraniuk JN, Lundgren JD, Shelhamer JH, Kaliner MA.

    Allergenic Diseases Section, National Institute of Allergy and Infectious Disease, Bethesda, MD 20892.

    The autoradiographic binding site of gastrin releasing peptide (GRP), the 27 amino acid mammalian form of bombesin, were examined in human bronchial mucosa. 125I-GRP bound specifically to submucosal glands and the epithelium. There was limited binding to vessels and bronchial smooth muscle. These observations suggest that GRP or GRP immunoreactive peptides which are present in nerve fibres and pulmonary neuroendocrine cells, may act upon glandular GRP receptors to induce mucus secretion, but that GRP would probably have little effect on vascular permeability or tracheobronchial smooth muscle tone.

    PMID: 1557184 [PubMed - indexed for MEDLINE]

    Supplemental Content